{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:22:39Z","timestamp":1767871359792,"version":"3.49.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fujian Science and Technology Guidance Projects","award":["2021Y0098"],"award-info":[{"award-number":["2021Y0098"]}]},{"name":"Fujian Science and Technology Guidance Projects","award":["2020Y0006"],"award-info":[{"award-number":["2020Y0006"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to summarize the clinical characteristics, management, and outcomes, and to identify independent risk factors associated with the severity in a cohort of coronavirus disease 2019 (COVID-19) patients from early-pandemic Fujian Province, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 158 patients with confirmed COVID-19 were recruited from 10 designed hospitals of the Fujian province between January 22 and February 26, 2020. Their clinical, laboratory, computed tomography imaging, treatment, and outcome data were collected and summarized from electronic medical records. Potential independent risk factors associated with COVID-19 severity were explored by binary logistic multivariate regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 158 COVID-19 patients, 36 had mild, 106 had moderate, 8 had severe, and 8 had critical disease severity. The median age was 45\u202fyears (interquartile range 35\u201355) and 81 (51.3%) were men. 8.2% had a history of smoking. 31.6% had chronic underlying conditions, among which hypertension (13.9%), diabetes (7.6%), and liver disease (7.0%) were the most common. The most common initial symptom was fever, followed by cough, sputum expectoration, and muscle soreness. 94.3% of patients had abnormal imaging findings on chest computed tomography or X-ray. Patients with severe\/critical disease had significantly more prominent laboratory abnormalities, including an abnormal lymphocyte count and abnormal levels of white blood cells, albumin, aspartate aminotransferase, creatine kinase, lactate dehydrogenase, and D-dimer than mild\/moderate patients (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). Independent risk factors associated with severe\/critical disease included age \u2265 60\u202fyears [Odds ratio (OR)\u202f=\u202f19.9], WBC\u202f\u2265\u202f10\u202f\u00d7\u202f10\n                      <jats:sup>9<\/jats:sup>\n                      \/L (OR\u202f=\u202f47.5) and D-dimer &amp;gt; 0.5\u202fmg\/L (OR\u202f=\u202f5.0) (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.05). All patients received antiviral drugs; 126 (79.7%) also received traditional Chinese medicine and 29 (18.4%) received glucocorticoids. As of April 2, 133 patients (84.2%) were cured and discharged, 1 individual died (overall mortality, 0.6%), and the remaining 24 (15.2%) remained hospitalized after data gathering was completed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COVID-19 patients from Fujian province during early pandemic presented mostly as mild\/moderate cases with fever and cough as the initial symptoms. The detection of cellular immune function, coagulation function, myocardial damage, and liver function can help assess the severity of COVID-19. Specifically, the most important risk factors were older age, WBC elevation, and D-dimer elevation. Timely comprehensive treatment might be beneficial in controlling COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1622703","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:18Z","timestamp":1767854118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study of the clinical diagnosis and treatment of 158 cases of COVID-19"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiangqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xibin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxiang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baosong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.16288\/j.yczz.20-030","article-title":"The 2019 novel coronavirus resource","volume":"42","author":"Zhao","year":"2020","journal-title":"Yi Chuan Hered"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0242307","DOI":"10.1371\/journal.pone.0242307","article-title":"Clinical characteristics of 199 discharged patients with COVID-19 in Fujian Province: a multicenter retrospective study between January 22nd and February 27th, 2020","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS One"},{"key":"ref12","author":"Wang","year":"2020"},{"key":"ref13","year":""},{"key":"ref14","doi-asserted-by":"publisher","first-page":"11224","DOI":"10.18632\/aging.103370","article-title":"Treatment strategies of hospitalized patients with coronavirus disease-19","volume":"12","author":"Huang","year":"2020","journal-title":"Aging"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.jinf.2020.03.005","article-title":"Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients","volume":"80","author":"Liu","year":"2020","journal-title":"J Inf Secur"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2020.6130","article-title":"Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China","volume":"323","author":"Pan","year":"2020","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Inf Secur"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.46234\/ccdcw2025.124","article-title":"Smoking prevalence in urban and rural areas - China, 2024","volume":"7","author":"Zeng","year":"2025","journal-title":"China CDC Wkly"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/bmjebm-2020-111492","article-title":"Is there a smoker\u2019s paradox in COVID-19?","volume":"26","author":"Usman","year":"2021","journal-title":"BMJ Evid Based Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"586984","DOI":"10.3389\/fimmu.2020.586984","article-title":"Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and vaccines","volume":"11","author":"Reche","year":"2020","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.15537\/smj.2023.44.10.20230375","article-title":"The role of cross-reactive immunity to emerging coronaviruses: implications for novel universal mucosal vaccine design","volume":"44","author":"Alturaiki","year":"2023","journal-title":"Saudi Med J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e930853","DOI":"10.12659\/MSM.930853","article-title":"Epidemiological and clinical characteristics of 217 cases of COVID-19 in Jiangsu Province, China","volume":"27","author":"Zhou","year":"2021","journal-title":"Med Sci Monit"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e25645","DOI":"10.1097\/MD.0000000000025645","article-title":"Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: a single-center retrospective study","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajem.2020.12.003","article-title":"Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality","volume":"40","author":"Vafadar Moradi","year":"2021","journal-title":"Am J Emerg Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J Pathol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/resp.13196","article-title":"Mers, SARS and other coronaviruses as causes of pneumonia","volume":"23","author":"Yin","year":"2018","journal-title":"Respirology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","article-title":"COVID-19 presenting as stroke","volume":"87","author":"Avula","year":"2020","journal-title":"Brain Behav Immun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"w20293","DOI":"10.4414\/smw.2020.20293","article-title":"D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?","volume":"150","author":"Breakey","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1161\/STROKEAHA.120.030365","article-title":"Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China","volume":"51","author":"Qin","year":"2020","journal-title":"Stroke"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"256294","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jmv.25944","article-title":"Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection","volume":"92","author":"Xu","year":"2020","journal-title":"J Med Virol"},{"key":"ref34","first-page":"313","article-title":"COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection","volume":"13","author":"Bashash","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.12998\/wjcc.v9.i19.4980","article-title":"Liver injury in COVID-19: known and unknown","volume":"9","author":"Zhou","year":"2021","journal-title":"World J Clin Cases"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/bcp.15089","article-title":"Combination therapies for COVID-19: an overview of the clinical trials landscape","volume":"88","author":"Akinbolade","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"ref38","first-page":"22","article-title":"SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir","volume-title":"Rev Esp Quimioter","year":"2023"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa2033130","article-title":"A neutralizing monoclonal antibody for hospitalized patients with Covid-19","volume":"384","author":"Lundgren","year":"2021","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3760\/cma.j.issn.1674-2397.2021.02.001","article-title":"Diagnosis and treatment plan for coronavirus disease 2019 (trial version 8 revision)","volume":"14","year":"2021","journal-title":"Chin J Clin Infect Dis"},{"key":"ref41","first-page":"693","article-title":"Dexamethasone in Hospitalized Patients with Covid-19.","volume-title":"N Engl J Med","author":"Horby","year":"2021"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.jiph.2020.09.008","article-title":"Association of corticosteroids use and outcomes in COVID-19 patients: a systematic review and meta-analysis","volume":"13","author":"Tlayjeh","year":"2020","journal-title":"J Infect Public Health"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13054-020-02964-w","article-title":"Adjuvant corticosteroid therapy for critically ill patients with COVID-19","volume":"24","author":"Lu","year":"2020","journal-title":"Crit Care"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5694\/mja2.50577","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)","volume":"212","author":"Zha","year":"2020","journal-title":"Med J Aust"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2351040100","article-title":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids","volume":"235","author":"Griffith","year":"2005","journal-title":"Radiology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/s0140-6736(03)13085-1","article-title":"Hong Kong Hospital Authority working group on SARS, central Committee of Infection Control. Guideline on management of severe acute respiratory syndrome (SARS)","volume":"361","author":"Ho","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.200405-621WS","article-title":"Clinical issues and research in respiratory failure from severe acute respiratory syndrome","volume":"171","author":"Levy","year":"2005","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1622703\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:35:20Z","timestamp":1767854120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1622703\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":48,"alternative-id":["10.3389\/fpubh.2025.1622703"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1622703","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1622703"}}